Symbiance, Inc   Report issue

For profit Phase 2
Founded: Princeton NJ United States (1989)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2011
NCT01318226
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now